Nxstage Medical Inc (NXTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2004 | |
| Cash Flows From Operating Activities | |
| Net Income | -10,726 |
| Depreciation Amortization | 325 |
| Accounts receivable | -303 |
| Accounts payable and accrued liabilities | 1,112 |
| Other Working Capital | 434 |
| Other Operating Activity | -467 |
| Operating Cash Flow | $-9,625 |
| Cash Flows From Investing Activities | |
| PPE Investments | -59 |
| Other Investing Activity | -223 |
| Investing Cash Flow | $-282 |
| Cash Flows From Financing Activities | |
| Debt Repayment | -87 |
| Common Stock Issued | 5 |
| Other Financing Activity | 19,969 |
| Financing Cash Flow | $19,887 |
| Exchange Rate Effect | -13 |
| Beginning Cash Position | 8,881 |
| End Cash Position | 18,847 |
| Net Cash Flow | $9,966 |
| Free Cash Flow | |
| Operating Cash Flow | -9,625 |
| Capital Expenditure | -59 |
| Free Cash Flow | -9,684 |